Filing Flows › Phibro Animal Health (PAHC) › Q3 FY26
Phibro Animal Health (PAHC) Q3 FY26 earnings results (third quarter fiscal 2026)
10-Q filed May 6, 2026
Phibro Animal Health (PAHC) reported revenue of $384M for the third quarter fiscal 2026 (Q3 FY26), +10% from a year earlier and +3% from the quarter before. Operating margin was 11.6%, net earnings $24.0M (6.3% of revenue).
Phibro Animal Health, Q3 FY26: revenue $384M (+10% year over year), operating margin 11.6%, net earnings $24.0M, operating cash flow $16.2M. The chart follows the revenue to costs, profit and cash.
| Q3 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $384M | +3% | +10% |
| Gross profit | $126M | -5% | +20% |
| Operating profit | $44.7M | -11% | +33% |
| Net earnings | $24.0M | -13% | +15% |
| Operating cash flow | $16.2M | -16% | -62% |
| Free cash flow | $890K | -89% | -97% |
What changed
Revenue was $383.5M in Q3 FY26, up 10% year over year and up 3% from the previous quarter. MFAs and other was the largest line at 54% of revenue. MFAs and other added $24.1M year over year (up 13%), 68% of the total change. Performance Products declined 17%.
Gross margin was 32.8%, up 2.7 points from Q3 FY25. Operating profit was $44.7M, a 11.6% margin (up 2.0 points year over year). Of the extra revenue versus Q3 FY25, 31% reached operating profit, above the 10% margin then. Operating expenses grew 14% against revenue growth of 10%. Net earnings were $24.0M, up 15% year over year. The effective tax rate was 25.7%.
Operating cash flow was $16.2M (down 62% year over year), 67% of net earnings. Non-cash charges added back $12.4M of depreciation and amortization and $411K of share-based compensation. Working capital and other items used $20.7M. Capital expenditures of $15.3M left free cash flow of $890K.
Questions
What was Phibro Animal Health's revenue in the third quarter fiscal 2026?
Phibro Animal Health (PAHC) reported revenue of $384M for the third quarter fiscal 2026 (Q3 FY26), +10% from a year earlier and +3% from the quarter before.
Was Phibro Animal Health profitable in the third quarter fiscal 2026?
Operating profit was $44.7M (11.6% of revenue) and net earnings $24.0M.